ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2420

Frequent Self-Reported Pain and Disease Symptoms in Juvenile Idiopathic Arthritis Persist Despite Advances in Medication Therapies: An Electronic Diary Study

Maggie H. Bromberg1, Mark Connelly2, Kelly K. Anthony3, Karen M. Gil1 and Laura E. Schanberg4, 1Psychology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 2Integrative Pain Management, Children's Mercy Hospitals and Clinics, Kansas City, MO, 3Medical Psychology, Duke University Medical Center, Durham, NC, 4Pediatrics, Duke University Medical Center, Durham, NC

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Juvenile Arthritis, pain and pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatrics

Session Type: Abstract Submissions (ARHP)

Background/Purpose: Previous research has demonstrated that children with Juvenile Idiopathic Arthritis (JIA) experience frequent pain that interferes with performing tasks at home and at school. However, it is unclear whether pain and associated functional limitations persist despite recent advances in the understanding and medical treatment of the disease. The present study used electronic (e-) diaries to determine whether pain, stiffness, and fatigue continue to be common, disabling symptoms in children with JIA despite aggressive contemporary medical management.

Methods: Fifty-nine children with JIA (44 girls, 73% Caucasian, mean age 13.3 years) were recruited during routine pediatric rheumatology clinic visits. Most had mild (42%) or moderate (43%) physician-rated disease activity (minimal 11%, severe 4%). Participants provided current ratings of pain, stiffness, and fatigue intensity; number of painful locations; and functional limitations using a Smartphone e-diary three times each day for one month. Medication information was collected via parent report and checked for accuracy by chart review. Descriptive analyses were conducted to determine typical symptom intensity, frequency, and variability for the sample. Multilevel modeling was then used to analyze associations between symptoms and functional outcomes and between medication use and symptom intensity.

Results: Across 3258 completed e-diary entries, the average pain intensity rating was 26.3/100 (SD = 27.5), average stiffness intensity 24.4/100 (SD =25.2), and average fatigue intensity 42.7/100 (SD = 28.19). Children reported pain (>1/100) on 69% of e-diary entries.  No children were entirely pain-free across the reporting period. Children endorsed high pain (> 40/100) on 31% of all e-diaries with 86% reporting high pain at least once in study period. The majority of children in this sample were prescribed DMARDS (chart review 79%, caregiver report 54%). Biologics were the next most commonly prescribed medication (chart review 47%, caregiver report 32%). Few children were taking opioids (chart review 1%, caregiver report 3%). Medication type did not reliably predict differences in symptom intensity. Momentary pain intensity (t(3040) = 19.76, p < .01), number of painful locations (t(3039) = 8.44, p < .01), and stiffness intensity (t(3038) = 2.60, p < .01) uniquely predicted functional limitations, but fatigue intensity did not (t(3037) = -1.71, p= .09).

Conclusion:  Self-reported pain, stiffness, and fatigue continue to be common in children with JIA despite contemporary treatment advances including biologics. Prescribed medication class did not have a significant effect on reported symptoms. The findings are surprisingly consistent with previous results from paper daily diary research in the pre-biologic era. There remains a pressing ongoing need to optimize pain and symptom management in JIA.


Disclosure:

M. H. Bromberg,
None;

M. Connelly,
None;

K. K. Anthony,
None;

K. M. Gil,
None;

L. E. Schanberg,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/frequent-self-reported-pain-and-disease-symptoms-in-juvenile-idiopathic-arthritis-persist-despite-advances-in-medication-therapies-an-electronic-diary-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology